What androgens should be tested for in 11-beta-hydroxylase deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Androgen Testing for 11-Beta-Hydroxylase Deficiency

For suspected 11-beta-hydroxylase deficiency, measure testosterone, androstenedione, DHEA-S, and 17-OH-progesterone as initial androgens, with 11-deoxycortisol being the definitive diagnostic marker that distinguishes this from 21-hydroxylase deficiency. 1, 2, 3

Primary Diagnostic Androgens

The essential androgen panel for 11-beta-hydroxylase deficiency includes:

  • Testosterone - typically elevated in affected patients 1, 4
  • Androstenedione (Δ4-A) - markedly elevated and a key marker 1, 2, 5, 4
  • DHEA-sulfate (DHEA-S) - elevated in most cases 1
  • 17-OH-progesterone - modestly elevated (but less dramatically than in 21-hydroxylase deficiency) 1, 3

Critical Distinguishing Steroid

11-deoxycortisol (compound S) is the pathognomonic marker - it will be grossly elevated in 11-beta-hydroxylase deficiency while remaining normal in 21-hydroxylase deficiency 1, 2, 3, 5. This is the single most important test to differentiate between these two forms of congenital adrenal hyperplasia 3, 5.

Additional Useful Markers

  • 21-deoxycortisol - remains normal in 11-beta-hydroxylase deficiency but is elevated in 21-hydroxylase deficiency, providing another distinguishing feature 3, 5
  • Cortisol - typically low, which helps confirm adrenal enzyme deficiency 2, 5

Clinical Context and Pitfalls

The most common diagnostic error is misdiagnosing 11-beta-hydroxylase deficiency as 21-hydroxylase deficiency because both conditions present with elevated 17-OH-progesterone 1, 3. However, in 11-beta-hydroxylase deficiency, the 17-OH-progesterone rise is modest (e.g., from 92 to 133 nmol/L after ACTH stimulation), whereas in 21-hydroxylase deficiency it rises dramatically 1.

Studies suggest that approximately 1% of patients initially diagnosed with 21-hydroxylase deficiency actually have 11-beta-hydroxylase deficiency, indicating this condition is underdiagnosed 3. The key to avoiding this pitfall is measuring 11-deoxycortisol in all suspected cases of congenital adrenal hyperplasia 3, 5.

Practical Testing Approach

For newborn screening or initial workup:

  • Start with 17-OH-progesterone (will be elevated but not as dramatically as 21-hydroxylase deficiency) 2, 5
  • If positive, proceed immediately to second-tier testing with LC-MS/MS measuring 11-deoxycortisol, cortisol, androstenedione, and 21-deoxycortisol 2, 5
  • The pattern of markedly elevated 11-deoxycortisol with low cortisol and elevated androstenedione confirms the diagnosis 2, 5

Hypertension in a virilized infant strongly suggests 11-beta-hydroxylase deficiency rather than 21-hydroxylase deficiency, as the accumulated 11-deoxycorticosterone has mineralocorticoid activity 4.

Related Questions

What enzyme deficiency is likely responsible for the conversion of 17-hydroxyprogesterone to 11-deoxycortisol in a newborn with congenital adrenal hyperplasia (CAH) and electrolyte imbalance?
What is the primary cause and treatment of Congenital Adrenal Hyperplasia (CAH)?
What is the molecular pathophysiological explanation for the loss of salt (hyponatremia with hyperkalemia) in 21-hydroxylase (21-Hydroxylase) deficiency, versus the gain of salt (hypernatremia with hypokalemia) in 11-beta hydroxylase (11-beta Hydroxylase) deficiency, despite the latter producing a weak mineralocorticoid?
What is the difference between 17-hydroxylase deficiency and 21-hydroxylase deficiency?
What is the diagnosis and treatment for a patient with elevated 17-hydroxyprogesterone (17-OHP) and low random cortisol levels, suggestive of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency?
Should Eliquis (apixaban) and Plavix (clopidogrel) be continued or should Plavix (clopidogrel) and heparin be used?
Can stomach cancer (gastric cancer) with liver metastasis cause an elevated alpha-fetoprotein (AFP) level of more than 2000ng/mL in a patient with underlying early Child-Pugh B cirrhosis?
What are the common side effects of Paclitaxel (chemotherapy agent)?
What causes coronary artery spasms?
What is the recommended duration for anticoagulation therapy with Novel Oral Anticoagulants (NOACs) for resolution of apical thrombus?
What is the differential diagnosis and management approach for a patient presenting with tinnitus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.